Literature DB >> 14971633

Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors.

R Baldwin1, S Jeffries, A Jackson, C Sutcliffe, N Thacker, M Scott, A Burns.   

Abstract

BACKGROUND: Late-onset depressive disorder is associated with white matter lesions and neuropsychological deficits that in some studies are linked to a poorer outcome for depression. Some white matter lesions may be vascular in origin. This study investigated the relationship between response or non-response to antidepressant monotherapy and neuropsychological function, structural brain measures and vascular factors.
METHOD: This was a case control study. Fifty patients with late-onset major depressive disorder (29 who were responders to antidepressant monotherapy and 21 who were not) were compared with 35 non-depressed control subjects. Measures included assessment of vascular risk factors, neuropsychological testing and a magnetic resonance imaging (MRI) scan.
RESULTS: After adjustment for depressed mood and medication at evaluation, both patient groups had significantly more impairment compared to control subjects on verbal learning tasks involving immediate or delayed recall. Patients who did not respond to antidepressant monotherapy had significantly poorer performance than controls on tests involving visuospatial ability, language, word recognition and tests of executive function, whereas there were no differences between control subjects and responders. On two tests of executive function (verbal fluency and the Stroop test) non-responders scored significantly worse than responders. There were no significant group differences on MRI measures of atrophy or of white matter lesions apart from a higher periventricular hyperintensity score in non-responders compared to controls. There were no group differences on measures of vascular disease.
CONCLUSION: The results lend support to the emerging evidence that resistance to treatment in late-onset depression may be associated with impaired executive function. Subtle cerebrovascular mechanisms may be involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971633     DOI: 10.1017/s0033291703008870

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  24 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 2.  A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.

Authors:  Monique A Pimontel; David Rindskopf; Bret R Rutherford; Patrick J Brown; Steven P Roose; Joel R Sneed
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-21       Impact factor: 4.105

3.  Neurocognitive correlates of response to treatment in late-life depression.

Authors:  Tyler J Story; Guy G Potter; Deborah K Attix; Kathleen A Welsh-Bohmer; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2008-08-12       Impact factor: 4.105

4.  Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders.

Authors:  Luis García-Fabela; Efrén Melano-Carranza; Sara Aguilar-Navarro; Juan Miguel Antonio García-Lara; Luis Miguel Gutiérrez-Robledo; José Alberto Avila-Funes
Journal:  Rev Invest Clin       Date:  2009 Jul-Aug       Impact factor: 1.451

Review 5.  Diagnosis and treatment of depression and cognitive impairment in late life.

Authors:  Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos
Journal:  Ann N Y Acad Sci       Date:  2015-02-05       Impact factor: 5.691

Review 6.  The vascular depression hypothesis: mechanisms linking vascular disease with depression.

Authors:  W D Taylor; H J Aizenstein; G S Alexopoulos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

7.  Corticostriatothalamic reward prediction error signals and executive control in late-life depression.

Authors:  A Y Dombrovski; K Szanto; L Clark; H J Aizenstein; H W Chase; C F Reynolds; G J Siegle
Journal:  Psychol Med       Date:  2014-10-16       Impact factor: 7.723

8.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.

Authors:  Marianne Gorlyn; John G Keilp; Michael F Grunebaum; Bonnie P Taylor; Maria A Oquendo; Gerard E Bruder; Jonathan W Stewart; Gil Zalsman; J John Mann
Journal:  J Neural Transm (Vienna)       Date:  2008-07-16       Impact factor: 3.575

10.  The vascular depression subtype: evidence of internal validity.

Authors:  Joel R Sneed; David Rindskopf; David C Steffens; K Ranga Rama Krishnan; Steven P Roose
Journal:  Biol Psychiatry       Date:  2008-05-19       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.